JUMPCODE Genomics
1 known investors
Jumpcode Genomics develops programmable endonuclease enzymes for next-generation sequencing and PCR applications. The company's technology enables researchers to remove uninformative sequences and improve data quality for genomics applications including single-cell analysis, microbiome characterization, and infectious disease detection.